David J. Cullen
The Royal Free Hospital, Royal Free London NHS Foundation Trust
Papers
3
Total Citations
54
H-Index
3
About
David J. Cullen is a urologic surgeon and clinical researcher whose work centers on evidence-based, nephron-sparing management of kidney cancer, particularly small renal masses (SRMs). His landmark contributions include leading the NEST feasibility trial, a cohort-embedded randomized controlled trial comparing percutaneous cryoablation to robot-assisted partial nephrectomy—a study that directly addressed the historical failure of classical RCTs in this space. This work, alongside its companion protocol paper, has garnered over 40 citations and is reshaping how clinicians approach SRM treatment decisions, emphasizing reduced overtreatment and health burden. Cullen has also advanced perioperative care in upper tract urothelial carcinoma, demonstrating the safety and feasibility of early single-dose mitomycin C instillation after robot-assisted radical nephroureterectomy. His research is distinguished by its pragmatic trial designs and direct clinical applicability, bridging surgical innovation with rigorous methodology. With a growing citation footprint and a focus on high-level evidence for common urologic cancers, Cullen is a rising voice in kidney cancer surgery, advocating for personalized, minimally invasive strategies that prioritize both oncologic control and renal function preservation.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3